ID

19358

Descripción

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT00485498

Link

https://clinicaltrials.gov/show/NCT00485498

Palabras clave

  1. 21/12/16 21/12/16 -
Subido en

21 de diciembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00485498

Eligibility Schizophrenia NCT00485498

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female subjects, aged 18 - 60
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
subjects must meet a clinical diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according to dsm-iv
Descripción

Schizophrenia | Schizophreniform Disorders | Schizoaffective Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036358
UMLS CUI [3]
C0036337
subjects' illness must not, in the opinion of the investigator, be caused by substance abuse
Descripción

Illness caused by Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0038586
bprs total score (1 to 7 scale) of greater than or equal to 36 at visit 1
Descripción

Brief Psychiatric Rating Scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029941
subjects must have a minimum total score of greater than or equal to 14 on the five items of the panss-ec and at least one individual item score of greater than or equal to 4 using the 1-7 scoring system prior to first dose of double-blind medications
Descripción

Positive and negative syndrome scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451383
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with antipsychotics or benzodiazepines within 4 hours prior to the first study drug administration
Descripción

Antipsychotic Agents | Benzodiazepines

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0005064
treatment with an injectable depot neuroleptic within 1 injection interval prior to study drug administration
Descripción

Injection of depot antipsychotic agent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2585377
electroconvulsive therapy (ect) within 1 month (90 days) prior to study entry (visit 1)
Descripción

Electroconvulsive Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013806
treatment with remoxipride within 6 months (180 days) prior to visit 1
Descripción

Remoxipride

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0073047
documented history of allergic reaction to study medications
Descripción

Allergic Reaction Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0013230

Similar models

Eligibility Schizophrenia NCT00485498

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female subjects, aged 18 - 60
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizophreniform Disorders | Schizoaffective Disorder
Item
subjects must meet a clinical diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according to dsm-iv
boolean
C0036341 (UMLS CUI [1])
C0036358 (UMLS CUI [2])
C0036337 (UMLS CUI [3])
Illness caused by Substance Use Disorders
Item
subjects' illness must not, in the opinion of the investigator, be caused by substance abuse
boolean
C0221423 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,3])
Brief Psychiatric Rating Scale
Item
bprs total score (1 to 7 scale) of greater than or equal to 36 at visit 1
boolean
C0029941 (UMLS CUI [1])
Positive and negative syndrome scale
Item
subjects must have a minimum total score of greater than or equal to 14 on the five items of the panss-ec and at least one individual item score of greater than or equal to 4 using the 1-7 scoring system prior to first dose of double-blind medications
boolean
C0451383 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antipsychotic Agents | Benzodiazepines
Item
treatment with antipsychotics or benzodiazepines within 4 hours prior to the first study drug administration
boolean
C0040615 (UMLS CUI [1])
C0005064 (UMLS CUI [2])
Injection of depot antipsychotic agent
Item
treatment with an injectable depot neuroleptic within 1 injection interval prior to study drug administration
boolean
C2585377 (UMLS CUI [1])
Electroconvulsive Therapy
Item
electroconvulsive therapy (ect) within 1 month (90 days) prior to study entry (visit 1)
boolean
C0013806 (UMLS CUI [1])
Remoxipride
Item
treatment with remoxipride within 6 months (180 days) prior to visit 1
boolean
C0073047 (UMLS CUI [1])
Allergic Reaction Investigational New Drugs
Item
documented history of allergic reaction to study medications
boolean
C1527304 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial